focus -WSS

focus

author：knowledge 2025-09-30 08:53:32 - browse：19122

President of Bayer U.S. Sebastian Guth speaks with STAT reporters at STAT's Boston headquarters, March 13, 2024 — Bayer's U.S. president, Sebastian Guth, emphasized at an interview at the STAT offices in Boston that the pharma company is no longer just focused on small molecules. Alissa Ambrose/STAT

German pharmaceutical company Bayer is expanding its U.S. pharma business significantly, despite corporate turmoil and pricing pressures that have led many in the drug industry to bemoan the potential end of the American biotech innovation boom.

Bayer’s C-suite has been on a soul-searching mission for the last year, spurred by new leadership and the realization that the company is, as new CEO Bill Anderson said earlier this month, “badly broken.”

The biggest fissure is the debt and litigation costs stemming from Bayers’s 2018 acquisition of agriculture firm Monsanto, but the aspirin-maker’s pharmaceutical portfolio is also facing strain. Some of Bayer’s top products, including the anticoagulant drug Xarelto and the eye medication Eylea, are under patent pressure. Xarelto is also one of the first drugs to be subject to Medicare price negotiations under the Inflation Reduction Act, though Johnson & Johnson owns U.S. rights to the drug.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： It's been 20 years since Dolly the sheep. Where's my clone?

WSS

Parkland mass shooting to be reenacted for lawsuit

Pharma needs to include young adults in clinical research

Slain Parkland victim's father speaks out following reenactment

Biotech lab space demand falls sharply

Rock icon Freddie Mercury pre

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

explore

focus

hotspot

Medical records are filled with copy

Does Medicare's free annual wellness visit do any good?

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout LOUD podcast: possible new ALS drug, artificial wombs

Duchenne breakthrough therapy leaves behind pioneering families

Lasker Awards 2023: Winners in biomedical research

Medical records are filled with copy

Ukraine and a new approach to mental health in war

Duchenne breakthrough therapy leaves behind pioneering families

Biotech stock slump in 2023: awaiting the turnaround

Wikipedia

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

US Marines prepare to be put on commercial ships to deter Iranian harassment in Strait of Hormuz

STAT Virtual Event: Putting AI to the Test

Medical student insurance fails on mental health care coverage

Pope greeted like rockstar, appears revitalized at 'Catholic Woodstock' in Portugal

Drug for rare kidney disease narrowly misses mark in clinical trial

leisure time

hotspot

explore

focus